NeuroMetrix, Inc. is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. The Company's products are used by physicians and patients, and include the Quell® wearable neuromodulation technology for chronic pain and the DPNCheck® point-of-care nerve conduction test for peripheral neuropathies such as diabetic neuropathy. They aim to provide solutions that improve patient outcomes and quality of life.
The Woburn headquarters serves as the central hub for research and development, engineering, manufacturing oversight, corporate administration, sales, and marketing operations.
The facility likely houses advanced R&D laboratories for neurotechnology and medical device development, engineering workshops, and corporate offices designed to foster innovation.
The work culture at NeuroMetrix AI likely emphasizes scientific rigor, innovation, collaboration between technical and commercial teams, and a patient-centric approach to product development, typical of a medical technology firm.
Its location in the Greater Boston area provides access to a rich talent pool from renowned universities and a vibrant ecosystem of biotech and medtech companies, crucial for innovation and partnerships.
NeuroMetrix AI primarily operates from its headquarters in Woburn, MA, USA. Its global presence for products like Quell® and DPNCheck® is achieved through direct sales in the US and a network of international distributors and strategic partnerships in various regions worldwide. This allows them to support sales, provide customer service, and manage regulatory affairs across different markets.
4B Gill Street
Woburn
MA
USA
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, NeuroMetrix, Inc.' leadership includes:
NeuroMetrix, Inc. has been backed by several prominent investors over the years, including:
Based on publicly available information, there have been no major high-profile executive hires or exits announced by NeuroMetrix, Inc. in the past 12 months. The core leadership team appears stable.
Discover the tools NeuroMetrix, Inc. uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
NeuroMetrix, Inc. commonly utilizes the email format combining the first initial with the last name. This is a prevalent pattern in many corporations, particularly in the technology and healthcare sectors.
[first_initial][last]@neurometrix.com
Format
sgozani@neurometrix.com
Example
80%
Success rate
GlobeNewswire • April 25, 2024
NeuroMetrix, Inc. reported its financial results for the first quarter ended March 31, 2024. Revenue was $1.2 million, a decrease from $1.8 million in Q1 2023. The net loss for the quarter was $1.3 million. The company highlighted ongoing commercial efforts for Quell and DPNCheck....more
GlobeNewswire • February 22, 2024
NeuroMetrix, Inc. announced its fourth quarter and full-year 2023 financial results. Full-year 2023 revenue was $6.5 million compared to $7.5 million in 2022. The company discussed progress with its DPNCheck device and Quell technology....more
GlobeNewswire • January 8, 2024
NeuroMetrix, Inc. provided a business update highlighting preliminary Q4 2023 revenues of approximately $1.5 million and reiterating its strategic focus on its DPNCheck and Quell product lines. The company also noted its participation in upcoming investor conferences....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including NeuroMetrix, Inc., are just a search away.